APA (7th ed.) Citation

Ottmann, O. G., Krämer, A., & Bochtler, T. (2019). Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia. British journal of haematology, 184(6), . https://doi.org/10.1111/bjh.15204

Chicago Style (17th ed.) Citation

Ottmann, Oliver G., Alwin Krämer, and Tilmann Bochtler. "Phase I Dose-escalation Trial Investigating Volasertib as Monotherapy or in Combination with Cytarabine in Patients with Relapsed/refractory Acute Myeloid Leukaemia." British Journal of Haematology 184, no. 6 (2019). https://doi.org/10.1111/bjh.15204.

MLA (9th ed.) Citation

Ottmann, Oliver G., et al. "Phase I Dose-escalation Trial Investigating Volasertib as Monotherapy or in Combination with Cytarabine in Patients with Relapsed/refractory Acute Myeloid Leukaemia." British Journal of Haematology, vol. 184, no. 6, 2019, https://doi.org/10.1111/bjh.15204.